PORTAGE BIOTECH INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Apr. 15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
| Apr. 12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
Chart calendar Portage Biotech Inc
4a0bad3c7cd539675e828a3f3454.e3UXzJ3_gsCS7W2XAU4v6D-gFyCxtLFuJoWNlV2h7Ok.HC1loOy39YzglTXnVzpiuknDXkL0xPU_Yeeg4CzjwYIrDHuv1pbVtNuVLA~212af68c567ab32a82517a6f8b70e81e
Upcoming events on Portage Biotech Inc
Past events on Portage Biotech Inc
| 2024-02-28 05:10 pm | Q3 2024 Earnings Release |
| 2023-11-28 04:01 pm | Q2 2024 Earnings Release |
| 2023-09-28 10:20 am | Cantor Global Healthcare Conference |
| 2023-09-11 | H.C. Wainwright Global Investment Conference |
| 2023-08-30 08:00 am | Q1 2024 Earnings Release |
| 2023-07-31 04:05 pm | Q4 2023 Earnings Release |
| 2023-06-08 10:15 am | BIO International Convention - Panel |
| 2023-03-14 02:00 pm | Oppenheimer Healthcare Conference |
| 2023-03-09 10:30 am | Investor Meeting - Key Opinion Leader |
| 2023-03-01 08:00 am | Q3 2023 Earnings Release |
| 2023-02-22 09:00 am | Citi Virtual Oncology Leadership Summit |
| 2022-11-29 04:43 pm | Interim 2023 Earnings Release |
| 2022-11-10 10:30 am | Annual General Meeting |
| 2022-11-10 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract No. - 745 |
| 2022-08-29 08:00 am | Q1 2023 Earnings Release |
| 2022-08-01 08:00 am | FY 2022 Earnings Release |
| 2022-07-07 08:30 am | Acquisition of Tarus Therapeutics by Portage Biotech, Inc Call |
| 2022-06-05 | American Society of Clinical Oncology Meeting - Abstract Number: 2520 |
| 2022-06-05 | American Society of Clinical Oncology Meeting - Abstract Number: 11515 |
| 2022-06-05 | American Society of Clinical Oncology Meeting - Abstract Number: 382017 |
Annual results
| Fiscal Period | March | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -15,6 -15,3 -1.84% | -16,6 -18,0 7.92% | -19,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,8 -15,1 2.19% | -123 -18,0 -580.68% | -62,4 |
|
Net income Million USD | Released Forecast Spread | -16,9 -13,7 -22.75% | -105 -16,0 -553.82% | -51,8 |
|
EPS USD | Released Forecast Spread | -1,29 -1,05 -22.86% | -6,49 -0,94 -590.43% | -2,72 |
| Announcement Date | 01/08/22 | 31/07/23 | - |
Quarterly results
| Fiscal Period | March | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,17 -3,60 -15.81% | -4,50 -4,24 -6% | -4,09 -4,38 6.67% | -3,65 -4,20 13.04% | -4,76 -3,88 -22.75% | -4,08 -5,00 18.48% | -5,00 -4,18 -19.62% | -5,93 -4,63 -27.99% | -4,03 -5,84 31.06% | -4,40 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,09 -4,00 -2.23% | -4,05 -4,26 5.08% | -4,18 -4,35 3.87% | -3,64 -4,53 19.77% | -5,30 -3,88 -36.76% | -109 -5,00 -2088.1% | -6,07 -4,18 -45.33% | -6,07 -4,63 -31.06% | -48,9 -5,82 -740.07% | -4,35 |
|
Net income Million USD | Released Forecast Spread | -3,51 -3,78 7.04% | -7,32 -3,78 -93.83% | -1,73 -4,05 57.26% | -0,95 -4,53 79.07% | -7,49 -3,88 -93.06% | -94,4 -5,00 -1788.96% | -5,92 -4,18 -41.69% | -5,16 -4,63 -11.33% | -39,4 -5,82 -576.74% | -4,35 |
|
EPS USD | Released Forecast Spread | -0,26 -0,27 4.88% | -0,55 -0,28 -98.79% | -0,13 -0,30 56.18% | -0,06 -0,29 79.31% | -0,44 -0,23 -95.56% | -6,00 -0,27 -2122.22% | -0,33 -0,24 -37.5% | -0,29 -0,27 -7.41% | -1,88 -0,27 -596.3% | -0,22 |
| Announcement Date | 24/02/22 | 01/08/22 | 29/08/22 | 29/11/22 | 01/03/23 | 31/07/23 | 29/08/23 | 28/11/23 | 28/02/24 | - |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Portage Biotech Inc
| Today 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- PRTG Stock
- Stock
- Calendar Portage Biotech Inc
